Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesProspective study of neuropsychiatric events in systemic lupus erythematosus
Journal of Rheumatology, 07/02/09
Hanly JG et al. – The association of lower health-related quality of life (HRQOL) with neuropsychiatric (NP) events over time, independent of progression in cumulative organ damage, emphasizes the persistent negative effect of NP events for pts with systemic lupus erythematosus (SLE).
Methods- Prospective study of NP events and their association with HRQOL over time in SLE pts
- Observational cohort study from single academic center for NP events and their attribution at enrollment and at annual assessments for up to 7 yrs
- NP events characterized by American College of Rheumatology case definitions
- Other variables: global SLE disease activity and cumulative organ damage
- Outcomes of NP events recorded and self-report HRQOL measured by mental (MCS) and physical (PCS) component summary scores of Medical Outcomes Study Short Form-36
- Of 209 pts: 88% female; 92% Caucasian, mean (SD) age 43.7 (13.8) yrs
- Follow-up for 175/209 (84%) pts
- Over mean follow-up of 3.6 (2.5) yrs, 299 NP events in 132/209 (63%) pts
- NP events attributed to SLE: 31% in 54 pts
- On multivariate analysis, lower MCS scores in pts with NP events vs those without events regardless of attribution
- Group means for PCS scores significantly lower in pts with NP events regardless of attribution
- No association between HRQOL and cumulative organ damage nor between NP events and organ damage progression
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial
The Lancet, 10/13/09
Sponsor
Article Search
Sponsor
Sponsor